Treatment of Alzheimer's disease: hopes and reality.
The relative failure of symptomatic therapeutic trials for Alzheimer's disease using non-selective cholinergic agonists brings about the need for longitudinal studies with parallel designs aimed at disease stabilization, using trophic substances or amyloid suppressors.
Gauthier
S
S
McGill Centre for Studies in Aging, Montreal, Quebec, Canada.
Gauthier
L
L
Bouchard
R
R
Quirion
R
R
Sultan
S
S
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use*; D011379:Prognosis; D011569:Psychiatric Status Rating Scales; D012107:Research Design; D016896:Treatment Outcome
D010277:Parasympathomimetics